These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12205657)

  • 1. No evidence for individual blood-brain barrier phenylalanine transport to influence clinical outcome in typical phenylketonuria patients.
    Pietz J; Rupp A; Burgard P; Boesch C; Kreis R
    Ann Neurol; 2002 Sep; 52(3):382-3; author reply 383-4. PubMed ID: 12205657
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenylalanine concentration in the cerebrospinal fluid and blood, both entering and leaving the brain, of phenylketonuria patients].
    Bulakhova LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1542-6. PubMed ID: 4775335
    [No Abstract]   [Full Text] [Related]  

  • 5. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
    Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.
    Knudsen GM; Hasselbalch S; Toft PB; Christensen E; Paulson OB; Lou H
    J Inherit Metab Dis; 1995; 18(6):653-64. PubMed ID: 8750601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual blood-brain barrier phenylalanine transport in siblings with classical phenylketonuria.
    Weglage J; Wiedermann D; Denecke J; Feldmann R; Koch HG; Ullrich K; Möller HE
    J Inherit Metab Dis; 2002 Oct; 25(6):431-6. PubMed ID: 12555936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain phenylalanine measurement in patients with phenylketonuria: a serious diagnostic method or just reading tea leaves?
    Bik-Multanowski M; Pietrzyk JJ
    Mol Genet Metab; 2007 Jul; 91(3):297-8. PubMed ID: 17482495
    [No Abstract]   [Full Text] [Related]  

  • 10. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc/LAT1 complex.
    Møller LB; Paulsen M; Koch R; Moats R; Guldberg P; Güttler F
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S119-23. PubMed ID: 16176881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria.
    Weglage J; Wiedermann D; Denecke J; Feldmann R; Koch HG; Ullrich K; Harms E; Möller HE
    Ann Neurol; 2001 Oct; 50(4):463-7. PubMed ID: 11601498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current problems in the diagnosis and treatment of phenylketonuria].
    Sanielevici-Marinov S; Anagnoste V; Mark E; Tomescu E; Iordache C
    Pediatria (Bucur); 1973; 22(1):1-12. PubMed ID: 4733556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phenylalanine and tyrosine in albino rat brain in the normal state and in experimental phenylketonuria].
    Kaplanskiĭ SIa; Akopian ZhI
    Ukr Biokhim Zh; 1967; 39(1):34-7. PubMed ID: 5628879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with diagnosis and treatment of phenylketonuria].
    Bodegård G; Zetterström R
    Lakartidningen; 1974 Mar; 71(12):1163-6. PubMed ID: 4821496
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Kreis R
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S126-8. PubMed ID: 11221741
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of diet on several metabolic indices in phenylketonuria].
    Bulakhova LA; Chernitskaia II; Usherenko LS
    Tsitol Genet; 1974; 8(1):31-3. PubMed ID: 4364293
    [No Abstract]   [Full Text] [Related]  

  • 18. Transport of amino acids across the blood-brain barrier: implications for treatment of maternal phenylketonuria.
    Gardiner RM
    J Inherit Metab Dis; 1990; 13(4):627-33. PubMed ID: 2122125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attempted physiopathologic interpretation of phenylketonuria (PKU)].
    Biserte G
    Lille Med; 1974 Feb; 19(2):134-40. PubMed ID: 4848103
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Möller HE; Ullrich K; Weglage J
    Eur J Pediatr; 2000 Oct; 159 Suppl 2():S121-5. PubMed ID: 11043158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.